Previous 10 | Next 10 |
Zynex ( ZYXI +10.4% ) reports 126% Y/Y order growth in Q1 and 3% sequentially growth. More news on: Zynex, Inc., Healthcare stocks news, Stocks on the move, , Read more ...
ENGLEWOOD, Colo. , April 7, 2020 /PRNewswire/ -- Zynex, Inc. (NASDAQ: ZYXI), an innovative medical technology company specializing in manufacturing and selling non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics, to...
ENGLEWOOD, Colo. , March 30, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostic...
We are currently faced with a global pandemic while at the same time faced with volatile oil prices. Many companies and industries will need a life-line to continue to stay in business. Management will face pressure from government officials with respect to capital allocation and share repurch...
Introduction The Weekly Breakout Forecast continues my doctoral research analysis on MDA breakout selections over more than 5 years. This subset of the different portfolios I regularly analyze has now reached 147 weeks of public selections as part of this ongoing live forward-testing. In...
Image source: The Motley Fool. Zynex, Inc (NASDAQ: ZYXI) Q4 2019 Earnings Call Feb 27, 2020 , 4:15 p.m. ET Operator Continue reading
Zynex, Inc. (ZYXI) Q4 2019 Earnings Conference Call February 27, 2020 4:15 PM ET Company Participants Thomas Sandgaard – Founder, Chairman and Chief Executive Officer Dan Moorhead – Chief Financial Officer Conference Call Participants Boobalan Pachaiyappan ...
Zynex (NASDAQ: ZYXI ): Q4 GAAP EPS of $0.09 beats by $0.01 . More news on: Zynex, Inc., Earnings news and commentary, Healthcare stocks news, Read more ...
ENGLEWOOD, Colo. , Feb. 27, 2020 /PRNewswire/ -- 2019 Full Year Revenue increased 42% year over year to $45.5 million Net income $9.5 million ; Diluted EPS $0.28 2019 Revenue, net income and Adjusted EBITDA are the highest in Company history Adjusted EBITDA incr...
ENGLEWOOD, Colo. , Feb. 25, 2020 /PRNewswire/ -- Zynex, Inc . (NASDAQ: ZYXI), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, stroke rehabilitation, cardiac monitoring and neurological diagnostics...
News, Short Squeeze, Breakout and More Instantly...
--News Direct-- Zynex Inc CEO Thomas Sandgaard joined Steve Darling from Proactive to announce the company's financial and operational results for the second quarter ending June 30, 2024, in an interview with Proactive. The company achieved a remarkable 20% year-over-year increase in orde...
2024-07-26 16:37:00 ET Shares of pain-management equipment specialist Zynex (NASDAQ: ZYXI) were falling in Friday trading, down as much as 23.4%, before recovering to a 13.4% decline as of 3:25 p.m. EDT. The medical equipment company reported earnings last night that, on a headl...
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) rose 22.6% to $0.0461 on volume of 144,150,002 shares Vintage Wine Estates Inc. (VWE) rose 21.5% to $0.0849 on volume of 35,620,484 shares NVIDIA Corporation (NVDA) rose 2.4% to $115.03 on volume of 35,381,...